View of Incidence of Grade 4 Neutropenia During the Nadir Period After the First Cycle of Doxorubicin and Cyclophosphamide Chemotherapy in Patients with Breast Cancer

Return to Article Details Incidence of Grade 4 Neutropenia During the Nadir Period After the First Cycle of Doxorubicin and Cyclophosphamide Chemotherapy in Patients with Breast Cancer Download Download PDF